Delayed Diabetes Medication Increases Heart Attack and Stroke Risk
Patients who delay starting medication after a type 2 diabetes diagnosis face significantly higher risks of heart attack, stroke, and heart failure compared to those who achieve early glycemic control. According to a study cited by TVBS, delaying intensive treatment for one year when HbA1c levels remain above 7% increases the risk of myocardial infarction by 67% and stroke by 51%.
The Cardiovascular Toll of Delayed Treatment
Research published in Cardiovascular Diabetology in 2015 tracked 105,477 patients diagnosed with type 2 diabetes after 1990 through 2012, with a median follow-up of 5.3 years.
The results showed the delayed-treatment group suffered a 64% higher risk of heart failure and a 62% increase in overall cardiovascular events. Lin explained that chronic high blood sugar acts like syrup on vessel walls; over time, sugars bind to proteins in the vessel walls, creating advanced glycation end products (AGEs) that harden the arteries and trigger persistent inflammation.
The Metabolic Memory Effect
The human body retains a “memory” of blood glucose levels, a phenomenon supported by the UK Prospective Diabetes Study (UKPDS). In that trial, the difference in HbA1c between an intensive glucose control group and a standard treatment group disappeared within a year after the trial ended. However, 10 years later, the intensive group still showed a 24% lower risk of microvascular complications, a 15% lower risk of heart attack, and a 13% lower risk of all-cause mortality.
Lin emphasized that this “metabolic memory” works both ways: while poor control in the first year creates long-term damage, early successful control provides a protective “dividend” for a decade or more.
High Blood Sugar Increases Risk of Kidney Failure
The kidneys are among the first organs to suffer from uncontrolled glucose. Lin pointed out that the glomeruli—the tiny blood vessels responsible for filtration—are particularly susceptible to the hardening effects of high blood sugar.
A study of 34,737 newly diagnosed patients over an average of 13 years found that those with an HbA1c between 6.5% and 7% in their first year had a 20% higher risk of dialysis, amputation, and severe retinopathy than those below 6.5%. For those above 7% in the first year, the risk of death also increased. Data from the UKPDS further indicates that every 1% reduction in HbA1c reduces microvascular complication risks by 37% and heart attack risks by 14%.
The Risk of “Lifestyle-First” Approaches
Many patients request a trial period of diet and exercise before starting medication. While Lin describes lifestyle changes as the foundation of treatment, the VERIFY trial published in The Lancet in 2019 suggests that starting medication immediately is more effective for some.
The trial divided 2,001 newly diagnosed patients into two groups: one starting with two oral medications and another starting with one, adding more only if needed. After five years, 62.1% of the single-drug group lost control of their blood glucose, compared to 43.6% of the dual-drug group. Lin noted that for patients with an HbA1c already above 9%, waiting six months to start medication may not be the most conservative choice.
Modern Medications and Organ Protection
Contrary to the belief that medication damages the kidneys, newer classes of drugs show protective effects. A meta-analysis of 13 trials involving 90,090 participants found that SGLT2 inhibitors reduced the risk of kidney disease progression by 37%, acute kidney injury by 23%, and cardiovascular death or heart failure hospitalization by 23%.
GLP-1 receptor agonists have been shown to reduce major kidney events by 24% in type 2 diabetes patients with existing chronic kidney disease, while slowing the annual decline of kidney function by 1 unit.
Diabetes Treatment Questions
Does starting medication immediately mean I can stop exercising or dieting?
No. Lin Xuan-ren states that diet and exercise remain the “foundation” of diabetes management, regardless of whether medication is used.
Can a person “reverse” diabetes if they wait to take medicine?
While lifestyle changes are critical, the VERIFY trial indicates that those who start with more intensive pharmacological therapy have a significantly lower rate of losing glycemic control over five years compared to those who start with a single drug or delayed approach.
Why are the kidneys specifically at risk?
About one-fifth of the blood pumped by the heart goes to the kidneys. The glomeruli are extremely fine microvessels that are among the first sites where sugar “sticks” to the vessel walls, making them difficult to recover once damaged.
Related reading